Animal NDC 54771-1108-1 L-s 50
Lincomycin Hydrochloride And Spectinomycin Sulfate Tetrahydrate
Animal Product Information
L-s 50 Animal Product Labeling Information
The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Table of Contents
Indications And Usage
For use in chickens up to 7 days of age as an aid in the control of: Airsacculitis caused by either Mycoplasma synoviae or Mycoplasma gallisepticum susceptible to lincomycin-spectinomycin. Complicated Chronic Respiratory Disease (Air Sac Infection) caused by Escherichia coli and M. gallisepticum susceptible to lincomycin-spectinomycin.
Complicated Chronic Respiratory Disease (Air Sac Infection) caused by Escherichia coli and M. gallisepticum susceptible to lincomycin-spectinomycin.
Dosage
Provide 2 grams (g) antibiotic activity per gallon of drinking water. Administer as the sole source of water for the first 5 to 7 days of life.
Administration
Amount of L-S 50 | Amount of Drinking Water |
---|---|
1 bottle | 25 gallons |
For proportioners delivering 1 ounce of solution per gallon of drinking water, dissolve contents of 5 bottles in each gallon of proportioner solution. |
Precaution
Discard medicated drinking water daily and replace with fresh medicated drinking water.
Warning
Not for human use.
Storage
Store at Controlled Room Temperature 20° to 25° C (68° to 77° F).
Principal Display Panel - 75 G Bottle Label
TAKE TIME
OBSERVE LABEL
DIRECTIONS
This bottle contains:
Lincomycin hydrochloride, equivalent to
lincomycin
16.7 grams
Spectinomycin sulfate tetrahydrate,
equivalent to spectinomycin
33.3 grams
Total Antibiotic Activity
50.0 grams
zoetis
Approved by FDA under NADA # 046-109
PEEL FROM THE RIGHT
FOR SPANISH LANGUAGE
NET WT. 2.65 OZ
(75.0 grams)
* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.